Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Winder Laboratories LLC, priced at $0.0757 per EA under NDC 75826013910. Its NADAC has been published 355 times since Sep 11, 2019.
Strength
32.4 mg/1
Manufacturer
Winder Laboratories LLCNDC
75826013910
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
6/11/2019
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 355 times since Sep 11, 2019, and over the history we have for it it has declined 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0757 per EA |
|---|---|
| All-time high | $0.4400 (Sep 11, 2019) |
| All-time low | $0.0757 (Jun 17, 2026) |
| 52-week high | $0.1625 |
| 52-week low | $0.0757 |
| Median price | $0.2189 |
| Average price | $0.2256 |
| Largest weekly change | +62.6% (Jun 19, 2024) |
| Weeks tracked | 355 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Winder Laboratories LLC, is $0.0757 per EA (NDC 75826013910), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 82.8%. It has been tracked across 355 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Sep 11, 2019, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0757 (Jun 17, 2026) to a high of $0.4400 (Sep 11, 2019), with a median of $0.2189 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 32.4 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 75826013910) is labeled by Winder Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification